# Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Study · id `cardio:ct-nct06271577` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06271577](<https://clinicaltrials.gov/study/NCT06271577>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06271577

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT06271577. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-12 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT06271577, source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)
- Started: 2024-03-12 (actual) (ClinicalTrials.gov record NCT06271577, source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06271577, source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)
- Completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT06271577, source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)
- Countries: United States; United Kingdom (ClinicalTrials.gov record NCT06271577, source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06271577-2026-04-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Acronym: STLEUISII
- Condition: Myocardial Infarction
- Condition: Ischemia
- Condition: Myocardial Ischemia
- Condition: Heart Diseases
- Condition: Cardiovascular Diseases
- Condition: Vascular Diseases
- Condition: Heart Attack
- Condition: Heart Failure
- Intervention (Device): AliveCor 12-lead ECG
- Lead sponsor: AliveCor
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: AliveCor (`cardio:org-alivecor`)

## Provenance

Content hash: b1d21393aa7de6116372d9bc3d18e039dc03411928f5a6ead0ddd38faeca1fc8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
